Research Topics
Genomes and Genes
| Jorge S Reis-FilhoSummaryAffiliation: Institute of Cancer Research Country: UK Publications
| Collaborators
|
Detail Information
Publications
Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotypeSunil R Lakhani
The Breakthrough Toby Robins Breast Cancer Research Centre, Institute of Cancer Research, London, United Kingdom
Clin Cancer Res 11:5175-80. 2005..To investigate the proportion of breast cancers arising in patients with germ line BRCA1 and BRCA2 mutations expressing basal markers and developing predictive tests for identification of high-risk patients...
Prognostic signatures in breast cancer: correlation does not imply causationCharlotte Ng
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London SW3 6JB, UK
Breast Cancer Res 14:313. 2012..These findings demonstrate that a statistical association between a gene signature and disease outcome does not necessarily imply biological significance...
Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and predictionPierre Emmanuel Colombo
Molecular Pathology Team, Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK
Breast Cancer Res 13:212. 2011..Here, we review the clinical relevance of microarray-based profiling of breast cancer and discuss its impact on patient management...
Transcriptome analysis of embryonic mammary cells reveals insights into mammary lineage establishmentOlivia Wansbury
Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK
Breast Cancer Res 13:R79. 2011..Despite these exciting properties, the molecular identity of embryonic mammary cells remains to be fully characterised...
Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancersHuiling Xu
Research Division, Peter MacCallum Cancer Centre, Locked Bag 1, A Beckett Street, Melbourne, VIC 8006, Australia
Breast Cancer Res 13:R9. 2011..We assessed its prognostic and predictive power in a cohort of in situ and invasive breast cancers, and its effect on chemosensitivity in vitro...
Breast cancer prognostic classification in the molecular era: the role of histological gradeEmad A Rakha
Department of Histopathology, Nottingham City Hospital NHS Trust, Nottingham University, Nottingham, UK
Breast Cancer Res 12:207. 2010....
Are triple-negative tumours and basal-like breast cancer synonymous?Emad A Rakha
Breast Cancer Res 9:404; author reply 405. 2007
Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survivalLaura G Fulford
Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, Fulham Road, London, SW3 6JB, UK
Breast Cancer Res 9:R4. 2007..Previous studies have suggested that expression of such 'basal' markers predicts different biological behaviour, with more frequent lung and brain metastases and poorer prognosis than other carcinomas...
Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell linesKevin C H Ha
Department of Human Genetics, McGill University, Montreal, Quebec, H3A 1B1, Canada
BMC Med Genomics 4:75. 2011..We sought to identify putative gene fusions in the transcriptomes of these cancers using high-throughput RNA sequencing (RNA-Seq)...
Revisiting the technical validation of tumour biomarker assays: how to open a Pandora's boxCaterina Marchio
Department of Biomedical Sciences and Human Oncology, University of Turin, Via Santena 7, 10126 Turin, Italy
BMC Med 9:41. 2011..Here we discuss the challenges for the technical validation of immunohistochemical and gene expression assays to detect tumour biomarkers and provide suggestions of pragmatic solutions to address these challenges...
Multiple immunofluorescence labelling of formalin-fixed paraffin-embedded (FFPE) tissueDavid Robertson
Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK
BMC Cell Biol 9:13. 2008..Consequently, there is a demand in the research community to be able to perform routine, high quality immunofluorescence labelling of FFPE tissues...
Pathologic quiz case: a 62-year-old woman with a 4.5-cm nodule in the right breast. Lipid-rich breast carcinomaJorge S Reis-Filho
Breakthrough Toby Robins Breast Cancer Research Centre, Institute of Cancer Research, London, United Kingdom
Arch Pathol Lab Med 127:e396-8. 2003
Is acinic cell carcinoma a variant of secretory carcinoma? A FISH study using ETV6'split apart' probesJ S Reis-Filho
Molecular Pathology Laboratory, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK
Histopathology 52:840-6. 2008..It has been demonstrated that SCs of the breast consistently harbour the t(12;15)ETV6-NTRK3 translocation. The aim was to determine whether ACCs also harbour ETV6 gene rearrangements and are thus variants of SCs...
Non-operative breast pathology: lobular neoplasiaJorge S Reis-Filho
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK
J Clin Pathol 60:1321-7. 2007..Furthermore, the current recommendations for the management of lobular neoplasia diagnosed on core needle biopsies proposed in the National Health Service Breast Cancer Screening guidelines are discussed...
Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysisJorge S Reis-Filho
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK
Mod Pathol 19:999-1009. 2006..The results of this study confirm the association between cyclin D1 overexpression and positivity for hormone receptors and the lack of CCND1 amplification in basal-like breast carcinomas...
Triple negative tumours: a critical reviewJ S Reis-Filho
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK
Histopathology 52:108-18. 2008..In addition, the possible mechanisms are discussed leading to BRCA1 pathway dysfunction in sporadic triple-negative and basal-like cancers and animal models for these tumour types...
Breast cancer special types: why bother?J S Reis-Filho
Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London SW3 6JB, UK
J Pathol 216:394-8. 2008..Here we review the molecular characteristics of special types of breast cancer, with special emphasis on their microarray-based expression profiles and their impact on our understanding of breast cancer...
Next-generation sequencingJorge S Reis-Filho
Molecular Pathology Team, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK
Breast Cancer Res 11:S12. 2009..Here, I discuss the potential impact of this technology on breast cancer research and the challenges that come with this technological breakthrough...
Molecular profiling: moving away from tumor philatelyJorge S Reis-Filho
Molecular Pathology Laboratory, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK
Sci Transl Med 2:47ps43. 2010..On the wave of recent scientific advances and clinical findings, new cutting-edge technologies are poised to deliver an array of diverse molecular data that are expected to dramatically alter breast cancer diagnosis and treatment...
Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entityJorge S Reis-Filho
The Breakthrough Toby Robins Breast Cancer Research Centre, Institute of Cancer Research, London SW3 6JB, UK
J Pathol 207:1-13. 2005..Taken together, these data suggest that at least some PLCs may evolve from the same precursor or through the same genetic pathway as classic lobular carcinomas...
Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell linesEdurne Arriola
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK
Lab Invest 88:491-503. 2008..The 17q12 amplicon is complex and harbours multiple genes that may be associated with breast cancer development and progression, and potentially exploitable as therapeutic targets...
Functional characterization of EMSY gene amplification in human cancersPaul M Wilkerson
Molecular Pathology Team, Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK
J Pathol 225:29-42. 2011..Taken together, this suggests that EMSY is unlikely to be a driver of the 11q13-q14 amplicon and does not have a dominant role in modulating the response to agents targeting cells with defective homologous recombination...
Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomasFelipe C Geyer
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK
J Pathol 220:562-73. 2010..This proof-of-principle study provides direct evidence of intra-tumour genetic heterogeneity in breast cancers, and shows that in some cases morphological diversity may be underpinned by distinct genetic aberrations...
DNA amplifications in breast cancer: genotypic-phenotypic correlationsKai Keen Shiu
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, 237 Fulham Road, London SW36JB, UK
Future Oncol 6:967-84. 2010....
Mucinous carcinoma of the breast is genomically distinct from invasive ductal carcinomas of no special typeMagali Lacroix-Triki
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK
J Pathol 222:282-98. 2010..Both components of mixed mucinous tumours are remarkably similar at the molecular level to pure mucinous cancers, suggesting that mixed mucinous carcinomas may be best classified as variants of mucinous cancers rather than of IDC-NSTs...
Distribution and significance of nerve growth factor receptor (NGFR/p75NTR) in normal, benign and malignant breast tissueJorge S Reis-Filho
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK
Mod Pathol 19:307-19. 2006..Furthermore, provisional data in a small number of basal-like breast carcinomas suggest that NGFR may identify a subgroup of basal-like breast carcinomas with good prognosis...
Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: a morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysisKay Savage
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, United Kingdom
Clin Cancer Res 13:90-101. 2007....
Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical studyKonstantin J Dedes
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK
Breast Cancer Res Treat 124:653-66. 2010..CTTN expression is not associated with the outcome of breast cancer patients treated with anthracycline-based chemotherapy...
Topoisomerase II alpha amplification may predict benefit from adjuvant anthracyclines in HER2 positive early breast cancerEdurne Arriola
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, Fulham Road, London SW3 6JB, UK
Breast Cancer Res Treat 106:181-9. 2007....
Breast cancer molecular profiling with single sample predictors: a retrospective analysisBritta Weigelt
Cancer Research UK, London Research Institute, London, UK
Lancet Oncol 11:339-49. 2010..Three microarray-based single sample predictors (SSPs) have been used to define molecular classification of individual samples. We aimed to establish agreement between these SSPs for identification of breast cancer molecular subtypes...
PPM1D gene amplification and overexpression in breast cancer: a qRT-PCR and chromogenic in situ hybridization studyMaryou B Lambros
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK
Mod Pathol 23:1334-45. 2010..Co-amplification of PPM1D and HER2/TOP2A and CCND1 are not random events and may suggest the presence of a 'firestorm' genetic profile...
Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple-negative and basal-like breast cancersDaniel Wetterskog
The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
J Pathol 226:84-96. 2012..Breast AdCCs constitute an entity distinct from grade-matched and triple-negative and basal-like IDC-NSTs, emphasizing the importance of histological subtyping of triple-negative and basal-like breast carcinomas...
Breast cancer precursors revisited: molecular features and progression pathwaysMaria A Lopez-Garcia
Molecular Pathology Team, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, 237 Fulham Road, London, UK
Histopathology 57:171-92. 2010....
Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patientsDavid S P Tan
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, 237 Fulham Road, London, SW3 6JB, UK
Breast Cancer Res Treat 111:27-44. 2008....
Tiling path genomic profiling of grade 3 invasive ductal breast cancersRachael Natrajan
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK
Clin Cancer Res 15:2711-22. 2009....
CD44 is overexpressed in basal-like breast cancers but is not a driver of 11p13 amplificationPamela Klingbeil
Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, 237 Fulham Road, London, SW3 6JB, UK
Breast Cancer Res Treat 120:95-109. 2010..Given that expression of CD44 is not an absolute requirement for the survival of cells harbouring CD44 gene amplification, CD44 is unlikely to be a driver of the 11p13 amplicon...
PPM1D is a potential therapeutic target in ovarian clear cell carcinomasDavid S P Tan
Department of Histopathology and Gynecologic Oncology, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, Royal Marsden Hospital, London, United Kingdom
Clin Cancer Res 15:2269-80. 2009..To identify therapeutic targets in ovarian clear cell carcinomas, a chemoresistant and aggressive type of ovarian cancer...
A high-resolution integrated analysis of genetic and expression profiles of breast cancer cell linesAlan Mackay
The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, Fulham Road, London, SW3 6JB, UK
Breast Cancer Res Treat 118:481-98. 2009..e., gains of 1q, 8q and 20q), basal-like and luminal cell lines are characterised by distinct genomic aberrations...
β-Catenin pathway activation in breast cancer is associated with triple-negative phenotype but not with CTNNB1 mutationFelipe C Geyer
Molecular Pathology Laboratory, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK
Mod Pathol 24:209-31. 2011..In conclusion, β-catenin/Wnt pathway activation is preferentially found in triple-negative/basal-like breast carcinomas, is associated with poor clinical outcome and is unlikely to be driven by CTNNB1 mutations in breast cancer...
Mixed micropapillary-ductal carcinomas of the breast: a genomic and immunohistochemical analysis of morphologically distinct componentsCaterina Marchio
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK
J Pathol 218:301-15. 2009....
A whole-genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor-negative and -positive breast cancersRachael Natrajan
The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, SW3 6JB, UK
J Pathol 227:29-41. 2012....
MYC amplification in breast cancer: a chromogenic in situ hybridisation studyS Maria Rodriguez-Pinilla
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK
J Clin Pathol 60:1017-23. 2007....
Microarray-based class discovery for molecular classification of breast cancer: analysis of interobserver agreementAlan Mackay
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, 237 Fulham Rd, London SW3 6JB, UK
J Natl Cancer Inst 103:662-73. 2011..The aim of this study was to determine the objectivity and interobserver reproducibility of the assignment of molecular subtype classes by hierarchical cluster analysis...
Functional characterization of the 19q12 amplicon in grade III breast cancersRachael Natrajan
Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, 237 Fulham Road, London, SW3 6JB, UK
Breast Cancer Res 14:R53. 2012..The aim of this study was to identify the genes within the 19q12 amplicon whose expression is required for the survival of cancer cells harbouring their amplification...
Non-existence of caveolin-1 gene mutations in human breast cancerNeill Patani
The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK
Breast Cancer Res Treat 131:307-10. 2012..Taken together with other studies, which have also failed to identify CAV1 mutations, our data call into question the existence and biological and clinical relevance of CAV1 gene mutations in human breast cancer...
Transcriptomic analysis of tubular carcinomas of the breast reveals similarities and differences with molecular subtype-matched ductal and lobular carcinomasMaria A Lopez-Garcia
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK
J Pathol 222:64-75. 2010....
Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysisPeter T Simpson
Breakthrough Toby Robins Breast Cancer Research Centre, Institute of Cancer Research, London, UK
Am J Surg Pathol 29:734-46. 2005..These data further support the hypothesis that CCLs are a nonobligate, intermediary step in the development of some forms of low grade in situ and invasive carcinoma...
Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selectionLucia Hernandez
Molecular Pathology Team, Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK
J Pathol 227:42-52. 2012....
The molecular genetics of breast cancer: the contribution of comparative genomic hybridizationJorge S Reis-Filho
The Breakthrough Toby Robins Breast Cancer Research Centre, Institute of Cancer Research, London, UK
Pathol Res Pract 201:713-25. 2005..CGH has been instrumental in dissecting distinct molecular pathways toward breast malignancy and in establishing a direct relationship between genotype and clinical pathological features...
Genomic and immunohistochemical analysis of adenosquamous carcinoma of the breastFelipe C Geyer
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK
Mod Pathol 23:951-60. 2010....
Microglandular adenosis or microglandular adenoma? A molecular genetic analysis of a case associated with atypia and invasive carcinomaFelipe C Geyer
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK
Histopathology 55:732-43. 2009..The aim of this study was to determine whether MGA is clonal and whether it harbours chromosomal aberrations similar to those found in matched invasive ductal carcinoma of no special type (IDC-NST)...
Metaplastic breast carcinomas exhibit EGFR, but not HER2, gene amplification and overexpression: immunohistochemical and chromogenic in situ hybridization analysisJorge S Reis-Filho
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK
Breast Cancer Res 7:R1028-35. 2005..We investigated whether HER2 and EGFR overexpression was present and evaluated gene amplification in a series of metaplastic breast carcinomas...
Conditional deletion of the Lkb1 gene in the mouse mammary gland induces tumour formationAfshan McCarthy
The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK
J Pathol 219:306-16. 2009..This mouse model of Lkb1 deficiency provides a potentially useful tool to investigate the role of Lkb1 in tumourigenesis and to guide the development of therapeutic approaches...
β-catenin/Wnt signalling pathway in fibromatosis, metaplastic carcinomas and phyllodes tumours of the breastMagali Lacroix-Triki
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK
Mod Pathol 23:1438-48. 2010..catenin nuclear expression should not be used as a single marker to differentiate fibromatosis from other spindle cell tumours of the breast...
An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancersRachael Natrajan
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK
Breast Cancer Res Treat 121:575-89. 2010..g. proliferation, HER2 and ER signalling) may be driven by specific patterns of copy number aberrations...
FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancerNicholas Turner
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, United Kingdom
Cancer Res 70:2085-94. 2010..Our data suggest that amplification and overexpression of FGFR1 may be a major contributor to poor prognosis in luminal-type breast cancers, driving anchorage-independent proliferation and endocrine therapy resistance...
PTEN deficiency in endometrioid endometrial adenocarcinomas predicts sensitivity to PARP inhibitorsKonstantin J Dedes
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, SW3 6JB London, UK
Sci Transl Med 2:53ra75. 2010..Given that up to 80% of endometrioid endometrial cancers lack PTEN expression, our results suggest that PARP inhibitors may be therapeutically useful for a subset of endometrioid endometrial cancers...
Loss of 16q in high grade breast cancer is associated with estrogen receptor status: Evidence for progression in tumors with a luminal phenotype?Rachael Natrajan
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London SW3 6JB, UK
Genes Chromosomes Cancer 48:351-65. 2009..Given that GI breast cancers harbor a luminal phenotype, our results suggest that if progression from GI to GIII breast cancer does happen, it may preferentially occur in breast cancers of luminal phenotype...
Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutationsKonstantin J Dedes
The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
Cell Cycle 10:1192-9. 2011..Here we discuss the evidence that the clinical use of PARP inhibition may be broader than targeting of cancers in BRCA1/2 germ-line mutation carriers...
APRIN is a cell cycle specific BRCA2-interacting protein required for genome integrity and a predictor of outcome after chemotherapy in breast cancerRachel Brough
Cancer Research UK Gene Function and Regulation Group, London, UK
EMBO J 31:1160-76. 2012....
Genomic profiling of mitochondrion-rich breast carcinoma: chromosomal changes may be relevant for mitochondria accumulation and tumour biologyFelipe C Geyer
The Breakthrough Breast Cancer Research Centre, ICR, 237 Fulham Road, London SW3 6JB, UK
Breast Cancer Res Treat 132:15-28. 2012....
BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cellsGemma Molyneux
The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK
Cell Stem Cell 7:403-17. 2010..They also demonstrate that when target cells for transformation have the potential for phenotypic plasticity, tumor phenotypes may not directly reflect histogenesis. This has important implications for cancer prevention strategies...
Nuclear NF-κB/p65 expression and response to neoadjuvant chemotherapy in breast cancerRobin L Jones
Academic Department of Biochemistry, Royal Marsden Hospital, London, UK
J Clin Pathol 64:130-5. 2011..To evaluate the clinicopathological associations and predictive value of the transcription factor NF-κB in a large series of breast cancer patients treated with neoadjuvant chemotherapy...
A novel, selective, and efficacious nanomolar pyridopyrazinone inhibitor of V600EBRAFSteven Whittaker
Signal Transduction Team, Section of Cell and Molecular Biology, Molecular Pathology Team, The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom
Cancer Res 70:8036-44. 2010..As expected, the growth rate in vivo of a wild-type BRAF human tumor xenograft model is unaffected by inhibitor 1t. In contrast, 1t elicits significant therapeutic responses in mutant BRAF-driven human melanoma xenografts...
A mouse model of melanoma driven by oncogenic KRASCarla Milagre
Signal Transduction Team, The Institute of Cancer Research, London, United Kingdom
Cancer Res 70:5549-57. 2010..These tumors invade and destroy the underlying muscles and cells derived from them can grow as subcutaneous tumors and colonize the lungs of nude mice. These data establish that oncogenic KRAS can be a founder event in melanomagenesis...
Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancerChris Jones
The Breakthrough Toby Robins Breast Cancer Research Centre, Institute of Cancer Research, London, United Kingdom
Cancer Res 64:3037-45. 2004..These data provide a framework for the interpretation of breast cancer molecular profiling experiments, the identification of potential new diagnostic markers, and development of novel indicators of prognosis...
Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression dataAnita Grigoriadis
Ludwig Institute for Cancer Research University College London Breast Cancer Laboratory, 91 Riding House Street, London, W1W 7BS, UK
Breast Cancer Res 8:R56. 2006....
Distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysisKay Savage
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK
Breast Cancer Res Treat 110:245-56. 2008..The aims of this study were to define the distribution of caveolin 2 (CAV2) in frozen and formalin fixed, paraffin embedded (FFPE) normal breast samples and the significance of CAV2 expression in breast cancer...
Unlocking pathology archives for molecular genetic studies: a reliable method to generate probes for chromogenic and fluorescent in situ hybridizationMaryou B K Lambros
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK
Lab Invest 86:398-408. 2006..In summary, this protocol enables the generation of probes mapping to any gene of interest that can be applied to FFPETS, allowing correlation of morphological features with gene copy number...
Genome-wide transcriptomic profiling of microdissected human breast tissue reveals differential expression of KIT (c-Kit, CD117) and oestrogen receptor-alpha (ERalpha) in response to therapeutic radiationCharlotte B Westbury
Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK
J Pathol 219:131-40. 2009..The findings are relevant to both fibrosis and atrophy occurring after radiotherapy for early breast cancer...
Genomic characterisation of acral melanoma cell linesSimon J Furney
Signal Transduction Team, Division of Cancer Biology, Institute of Cancer Research, London, UK
Pigment Cell Melanoma Res 25:488-92. 2012..Data are available at: http://rock.icr.ac.uk/collaborations/Furney_et_al_2012/...
Molecular evidence in support of the neoplastic and precursor nature of microglandular adenosisFelipe C Geyer
Molecular Pathology Team, The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
Histopathology 60:E115-30. 2012..The aims of this study were to determine whether MGAs harbour genetic alterations and if any such genetic aberrations found in MGAs are similar to those found in matched invasive carcinomas...
Integrated functional, gene expression and genomic analysis for the identification of cancer targetsElizabeth Iorns
The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom
PLoS ONE 4:e5120. 2009..In conclusion, this strategy represents a novel and effective strategy for the identification of functionally important therapeutic targets in cancer...
P63-driven nuclear accumulation of beta-catenin is not a frequent event in human neoplasmsJorge S Reis-Filho
The Breakthrough Toby Robins Breast Cancer Research Centre, Institute of Cancer Research, Chester Beatty Laboratories, London, UK
Pathol Res Pract 199:785-93. 2003..Caution should be exercised when translating the results of studies performed on cell lines to human neoplasms...
High-throughput detection of fusion genes in cancer using the Sequenom MassARRAY platformMaryou B K Lambros
Molecular Pathology Team, The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
Lab Invest 91:1491-501. 2011..In keeping with other highly sensitive assays, further refinement of this technique is necessary to reduce the number of false-positive results...
Absence of microsatellite instability in mucinous carcinomas of the breastMagali Lacroix-Triki
Molecular Pathology Team, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, SW3 6JB, UK
Int J Clin Exp Pathol 4:22-31. 2010..Our results demonstrate that MSI-high phenotype is remarkably rare in invasive breast cancer, and that, in contrast to mucinous carcinomas of other anatomical sites, MSI is not a common event in mucinous carcinomas of the breast...
Genomic analysis reveals the molecular heterogeneity of ovarian clear cell carcinomasDavid S P Tan
Department of Gynaecologic Oncology, Royal Marsden Hospital NHS Foundation Trust, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, Royal Marsden Hospital, London, United Kingdom
Clin Cancer Res 17:1521-34. 2011..Ovarian clear cell carcinomas (OCCC) are a drug-resistant and aggressive type of epithelial ovarian cancer. We analyzed the molecular genetic profiles of OCCCs to determine whether distinct genomic subgroups of OCCCs exist...
A marker of homologous recombination predicts pathologic complete response to neoadjuvant chemotherapy in primary breast cancerMonika Graeser
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, Academic Department of Biochemistry, and Breast Unit, Royal Marsden Hospital, London, United Kingdom
Clin Cancer Res 16:6159-68. 2010....
Chromogenic and fluorescent in situ hybridization in breast cancerMaryou B K Lambros
Molecular Pathology Laboratory, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, SW3 6JB London, UK
Hum Pathol 38:1105-22. 2007....
High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinomaTarek M A Abdel Fatah
Division of Pathology, School of Molecular Medical Sciences, University of Nottingham, Nottingham, London, UK
Am J Surg Pathol 31:417-26. 2007..Molecular studies are being performed to substantiate the hypothesis that tubular and lobular carcinomas have direct evolutionary links to CCLs and flat epithelial atypia...
Getting it right: designing microarray (and not 'microawry') comparative genomic hybridization studies for cancer researchDavid S P Tan
Molecular Pathology Team, The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK
Lab Invest 87:737-54. 2007....
Identification of direct transcriptional targets of (V600E)BRAF/MEK signalling in melanomaLeisl M Packer
Signal Transduction Team, Section of Cell and Molecular Biology, The Institute of Cancer Research, London, UK
Pigment Cell Melanoma Res 22:785-98. 2009..This study provides a basis for understanding the molecular processes that are regulated by (V600E)BRAF/MEK signalling in melanoma cells...
Identification of NTN4, TRA1, and STC2 as prognostic markers in breast cancer in a screen for signal sequence encoding proteinsSelma Esseghir
Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
Clin Cancer Res 13:3164-73. 2007..The purpose of this study was to assess the expression of these genes in human invasive breast tumors and to determine the significance of their expression for prognosis in breast cancer...
Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray-based CGH analysisCaterina Marchio
The Breakthrough Breast Cancer Research Centre Institute of Cancer Research, London, UK
J Pathol 219:16-24. 2009..0 in FISH analysis is frequently related to gain or amplification of the centromeric region. Larger studies investigating the genetic profiles of CEP17 polysomic cases are warranted...
The collagen receptor Endo180 (CD280) Is expressed on basal-like breast tumor cells and promotes tumor growth in vivoDirk Wienke
Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom
Cancer Res 67:10230-40. 2007..Together, these data argue that elevated expression of this receptor in tumor cells could have important consequences in subsets of basal-like carcinomas for which there is a current lack of effective treatment...
A role for glial cell derived neurotrophic factor induced expression by inflammatory cytokines and RET/GFR alpha 1 receptor up-regulation in breast cancerSelma Esseghir
Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom
Cancer Res 67:11732-41. 2007....
Resistance to therapy caused by intragenic deletion in BRCA2Stacey L Edwards
The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK
Nature 451:1111-5. 2008..6174delT mutation carriers. These observations have implications for understanding drug resistance in BRCA mutation carriers as well as in defining functionally important domains within BRCA2...
Distribution and significance of 14-3-3sigma, a novel myoepithelial marker, in normal, benign, and malignant breast tissuePeter T Simpson
The Breakthrough Toby Robins Breast Cancer Research Centre, Institute of Cancer Research, London, UK
J Pathol 202:274-85. 2004..This analysis demonstrates the utility of 14-3-3sigma as a new adjunct antibody for characterization of myoepithelial cells and myoepithelial lesions and it may be a novel prognostic factor for breast cancer patients...
Molecular cytogenetic identification of subgroups of grade III invasive ductal breast carcinomas with different clinical outcomesChris Jones
The Breakthrough Toby Robins Breast Cancer Research Centre, Institute of Cancer Research, London, UK
Clin Cancer Res 10:5988-97. 2004..Robust characterization of this basal group is necessary if it is to have a major impact on management of patients with breast cancer...
The role of molecular analysis in breast cancerFelipe C Geyer
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK
Pathology 41:77-88. 2009..This review will address the contribution of molecular methods to our understanding of breast cancer and its precursors, their use in breast cancer translational research and their impact on diagnostic breast cancer histopathology...
Aurora-A regulation of nuclear factor-kappaB signaling by phosphorylation of IkappaBalphaParaskevi Briassouli
The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, 237 Fulham Road, London, United Kingdom
Cancer Res 67:1689-95. 2007....
Cytokeratin 5/6 in normal human breast: lack of evidence for a stem cell phenotypeCatherine L Clarke
Breakthrough Toby Robins Breast Cancer Research Centre, Institute of Cancer Research, London, UK
J Pathol 204:147-52. 2004..This study brings into question the previously described profile of breast 'stem cells' based on CK5/6 staining and hence the breast cancer progression model and classification based on this phenotype...
The diagnosis and management of pre-invasive breast disease: pathology of atypical lobular hyperplasia and lobular carcinoma in situPeter T Simpson
The Breakthrough Toby Robins Breast Cancer Research Centre, Institute of Cancer Research, London, UK
Breast Cancer Res 5:258-62. 2003..LCIS is now considered a risk factor and a non-obligate precursor for the subsequent development of invasive cancer...
The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancerRobin L Jones
Academic Department of Biochemistry, Royal Marsden Hospital, London, UK
Breast Cancer Res Treat 116:53-68. 2009..To compare the prognostic significance of proliferation, as assessed by Ki67 expression, in breast cancer before and after neoadjuvant chemotherapy...
Next-generation sequencing applied to molecular diagnosticsRachael Natrajan
Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, 237 Fulham Road, London, SW3 6JB, UK
Expert Rev Mol Diagn 11:425-44. 2011..This article focuses on the contribution of next-generation sequencing technologies to diagnosis and cancer prognostication and prediction...
Direct evidence for concurrent morphological and genetic heterogeneity in an invasive ductal carcinoma of triple-negative phenotypeNeill Patani
The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK
J Clin Pathol 64:822-8. 2011..The results provide additional direct evidence of intra-tumour genetic heterogeneity in breast cancer and demonstrate that morphologically distinct regions can be associated with distinct genetic aberrations...
Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarrayJorge S Reis-Filho
The Breakthrough Toby Robins Breast Cancer Research Centre, Institute of Cancer Research, London, UK
Virchows Arch 443:122-32. 2003..Our results demonstrate that p63, CK 5/6 and CK 14 may be used together in immunohistochemical panels to characterize squamous differentiation in poorly differentiated carcinomas or carcinomas of unknown origin...
Genetic interactions in cancer progression and treatmentAlan Ashworth
The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK
Cell 145:30-8. 2011..Here, we discuss the implications of these findings for cancer progression and heterogeneity and for the development of new therapeutic approaches...
Evaluation of Phi29-based whole-genome amplification for microarray-based comparative genomic hybridisationEdurne Arriola
The Breakthrough Breast Cancer Research Centre, Institute of Cancer Research, London, UK
Lab Invest 87:75-83. 2007..For accurate results using Phi29 amplification, samples subjected to aCGH analysis should be combined with reference DNA amplified with the same method, using similar amounts of starting template...
Gene expression profiling in breast cancer: classification, prognostication, and predictionJorge S Reis-Filho
The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, UK jorge reis fi
Lancet 378:1812-23. 2011..In this review, we focus on the conceptual effect and potential clinical use of the molecular classification of breast cancer, and discuss prognostic and predictive multigene predictors...
c-KIT overexpression, without gene amplification and mutation, in paediatric renal tumoursChris Jones
Paediatric Oncology, Institute of Cancer Research Royal Marsden NHS Trust, Sutton, UK
J Clin Pathol 60:1226-31. 2007..To investigate the presence and prognostic relevance of KIT expression in paediatric renal tumours, and to determine whether receptor overexpression is associated with gene amplification and/or mutation...
